Daiichi Sankyo Co Ltd Ord (DSKYF) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Ladies and gentlemen, thank you very much for your patience. Now we would like to start FI 2025 third quarter financial results presentation. I am from corporate communication. My name is Asakura. I will be facilitating today's session. In this presentation, we are going to use Japanese and English. We have simultaneous interpretation service available. Please click on the interpretation icon at the bottom of the screen and please select the language of your choice. If you choose original audio, you should be able to hear original audio. And then on the Zoom screen, on the live streaming, we are going to put up Japanese presentation material. we have uploaded Japanese and English presentation material in our library on our corporate website whenever necessary please feel free to download the material Today's presenters are Mr. Ogawa, Senior Executive Officer, CFO, Mr. Abe, Head of R&D Division, and Mr. Ken Keller, Head of Global Oncology Business. Now, Ogawa and Abe are going to take you through the financial results for the third quarter FI 2025, and then we are going to open the floor for the Q&A. Today's session will be recorded. I would like to ask for your cooperation. Now, Ogawa-san, please. This is Ogawa. Thank you for participating in Daichi Sankyo's earnings briefing today, despite your busy schedule. Now I will explain the consolidated financial results for the third quarter of fiscal year 2025, announced at 15 o'clock today, based on the materials. Please look at slide 3. The content I will discuss today is as follows. Fiscal year 2025, third quarter consolidated financial results, business update, research and development update. The research and development update will be explained by ABI, head of the R&D unit. We will take your questions at the end. Ple...